Aprea Therapeutics Inc. (APRE) Reveals an Earnings Mystery – News Heater
Home  »  Business   »  Aprea Therapeutics Inc. (APRE) Reveals an Earnings...

Aprea Therapeutics Inc. (APRE) Reveals an Earnings Mystery

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Aprea Therapeutics Inc. (NASDAQ:APRE) went up by 4.88% from its latest closing price compared to the recent 1-year high of $30.99. The company’s stock price has collected -3.80% of loss in the last five trading sessions. Press Release reported on 11/08/21 that Aprea Therapeutics Reports Third Quarter 2021 Financial Results and Provides Update on Business Operations

Is It Worth Investing in Aprea Therapeutics Inc. (NASDAQ :APRE) Right Now?

Opinions of the stock are interesting as 0 analysts out of 5 who provided ratings for Aprea Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 3 rated it as “hold,” and 2 as “sell.”


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


The average price from analysts is $4.00, which is -$0.3 below the current price. APRE currently public float of 19.36M and currently shorts hold a 4.62% ratio of that float. Today, the average trading volume of APRE was 1.53M shares.

APRE’s Market Performance

APRE stocks went down by -3.80% for the week, with a monthly drop of -15.02% and a quarterly performance of 2.63%, while its annual performance rate touched -82.56%. The volatility ratio for the week stands at 7.43% while the volatility levels for the past 30 days are set at 5.71% for Aprea Therapeutics Inc.. The simple moving average for the period of the last 20 days is -10.39% for APRE stocks with a simple moving average of -12.25% for the last 200 days.

Analysts’ Opinion of APRE

Berenberg, on the other hand, stated in their research note that they expect to see APRE reach a price target of $37. The rating they have provided for APRE stocks is “Buy” according to the report published on December 16th, 2020.

JP Morgan gave a rating of “Neutral” to APRE, setting the target price at $25 in the report published on September 29th of the previous year.

APRE Trading at -12.94% from the 50-Day Moving Average

After a stumble in the market that brought APRE to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -86.13% of loss for the given period.

Volatility was left at 5.71%, however, over the last 30 days, the volatility rate increased by 7.43%, as shares sank -11.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.33% lower at present.

During the last 5 trading sessions, APRE fell by -3.80%, which changed the moving average for the period of 200-days by -47.24% in comparison to the 20-day moving average, which settled at $4.77. In addition, Aprea Therapeutics Inc. saw -12.60% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at APRE starting from Korbel Gregory Alan, who sale 27,500 shares at the price of $5.00 back on Nov 01. After this action, Korbel Gregory Alan now owns 17,167 shares of Aprea Therapeutics Inc., valued at $137,500 using the latest closing price.

Korbel Gregory Alan, the SVP, Chief Business Officer of Aprea Therapeutics Inc., sale 27,500 shares at $4.89 during a trade that took place back on Oct 01, which means that Korbel Gregory Alan is holding 17,167 shares at $134,475 based on the most recent closing price.

Stock Fundamentals for APRE

Equity return is now at value -68.60, with -58.30 for asset returns.

>> 7 Top Picks for the Post-Pandemic Economy <<

Sign up for our FREE Newsletter and get:

Leave a Comment

Your email address will not be published. Required fields are marked *

Sign up for our FREE Newsletter and get:

A Lesson to Learn: Deere & Company (DE)

Deere & Company (NYSE:DE) went up by 2.66% from its latest closing price compared to the recent 1-year high of $400.34. The company’s stock price

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

Heading

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam